Javascript must be enabled to continue!
Prevalence of cryptococcal meningitis among HIV patients attending Central University Hospital of Kigali
View through CrossRef
Background: Cryptococcal meningitis (CM) is a severe fungal infection caused primarily by Cryptococcus neoformans and less commonly by Cryptococcus gattii. It poses a significant threat to individuals with compromised immune systems, particularly those living with Human Immunodeficiency Virus (HIV). Despite advancements in antiretroviral therapy (ART), CM remains a leading cause of mortality among HIV-infected individuals, especially in low- and middle-income countries.
Aim: This study was done to determine the prevalence of Cryptococcus among HIV-infected patients attending at Central University Hospital of Kigali, Rwanda and the level at which a patient’s CD4 count is significantly associated with cryptococcal meningitis.
Methodology: A retrospective study was conducted at Central University Hospital of Kigali, Rwanda. This study included 60 HIV-infected patients whose serum and CSF samples were examined for Cryptococcus by one of or all 4 tests (CSF culture, CSF CrAg, serum CrAg and Indian Ink) and their results were recorded.
Results: Among the 60 HIV-infected patients enrolled, 8 (13%) were positive for cryptococcal meningitis. Among these 8 patients the CD4 count ranged from 2-200 cells/ul, and 31.82% (7 of 8) was among patients with CD4 count ≤100 c/ul and 6.25% (1 of 8) was among patients with CD4 count levels between 101 c/ul and 200c/ul. Based on the study results, CD4 count levels lower or equal to 100 cells/ul was highly associated with cryptococcal meningitis as the P-value=0.001 and Odd ratio=0.058.
Conclusion: Based on the study results there was a significant association between cryptococcal meningitis and lower CD4 count levels. HIV-infected patients with CD4 counts ≤100 cells had the highest prevalence. Therefore, the level of CD4 count below or equal to 100 cells/ul is highly associated with positive cryptococcal meningitis. However, there were cases of positive CM among HIV patients with CD4 count ≥100 cells/ul.
Keywords: Cryptococcal meningitis, CD4 count, HIV,
Title: Prevalence of cryptococcal meningitis among HIV patients attending Central University Hospital of Kigali
Description:
Background: Cryptococcal meningitis (CM) is a severe fungal infection caused primarily by Cryptococcus neoformans and less commonly by Cryptococcus gattii.
It poses a significant threat to individuals with compromised immune systems, particularly those living with Human Immunodeficiency Virus (HIV).
Despite advancements in antiretroviral therapy (ART), CM remains a leading cause of mortality among HIV-infected individuals, especially in low- and middle-income countries.
Aim: This study was done to determine the prevalence of Cryptococcus among HIV-infected patients attending at Central University Hospital of Kigali, Rwanda and the level at which a patient’s CD4 count is significantly associated with cryptococcal meningitis.
Methodology: A retrospective study was conducted at Central University Hospital of Kigali, Rwanda.
This study included 60 HIV-infected patients whose serum and CSF samples were examined for Cryptococcus by one of or all 4 tests (CSF culture, CSF CrAg, serum CrAg and Indian Ink) and their results were recorded.
Results: Among the 60 HIV-infected patients enrolled, 8 (13%) were positive for cryptococcal meningitis.
Among these 8 patients the CD4 count ranged from 2-200 cells/ul, and 31.
82% (7 of 8) was among patients with CD4 count ≤100 c/ul and 6.
25% (1 of 8) was among patients with CD4 count levels between 101 c/ul and 200c/ul.
Based on the study results, CD4 count levels lower or equal to 100 cells/ul was highly associated with cryptococcal meningitis as the P-value=0.
001 and Odd ratio=0.
058.
Conclusion: Based on the study results there was a significant association between cryptococcal meningitis and lower CD4 count levels.
HIV-infected patients with CD4 counts ≤100 cells had the highest prevalence.
Therefore, the level of CD4 count below or equal to 100 cells/ul is highly associated with positive cryptococcal meningitis.
However, there were cases of positive CM among HIV patients with CD4 count ≥100 cells/ul.
Keywords: Cryptococcal meningitis, CD4 count, HIV,.
Related Results
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
HIV WGS - 400bp Amplicon Tiling - Oxford Nanopore Technology Protocol v1
OSPHL in collaboration with APHL, will evaluate the performance of the Oxford Nanopore Technology sequencers for HIV genome sequencing using a modified protocol of the ARTIC amplic...
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
The Hidden Problem of Cross-Reactivity: Challenges in HIV Testing During the COVID-19 Era: A Systematic Review
Abstract
Introduction
Human immunodeficiency virus (HIV) and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) surface glycoproteins, including shared epitope motifs, sho...
Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study
Prevalence of Asymptomatic Cryptococcal Antigenemia and Association with Follow-up Risk of Cryptococcal Meningitis and Mortality among HIV Infected Patients in North West India: A Prospective Cohort Study
Objective:
Cryptococcal meningitis is an important cause of morbidity and mortality in
HIV infected individuals. In the era of universal antiretroviral therapy, the incidence of im...
Characterization of host response to
Cryptococcus neoformans
through quantitative proteomic analysis of cryptococcal meningitis co-infected with HIV
Characterization of host response to
Cryptococcus neoformans
through quantitative proteomic analysis of cryptococcal meningitis co-infected with HIV
Abstract
Cryptococcal meningitis is the most common opportunistic fungal infection causing morbidity and mortality (>60%) in HIV-associated immunocompromis...
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
Capítulo 6 – HIV-AIDS, como tratar, o que fazer e o que não fazer durante o tratamento?
A infecção pelo vírus do HIV pode ocorrer de diversas maneiras, tendo sua principal forma a via sexual por meio do sexo desprotegido. O vírus do HIV fica em um período de incubação...
Screening of cryptococcal antigen among HIV-positive patients with low CD4 count in a tertiary care Centre
Screening of cryptococcal antigen among HIV-positive patients with low CD4 count in a tertiary care Centre
Context:
Cryptococcal meningitis is an opportunistic fungal infection which is seen among people with compromised cell-mediated immunity....
High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
High burden of cryptococcal antigenemia and meningitis among patients presenting at an emergency department in Maputo, Mozambique
Background
Cryptococcal meningitis is a leading cause of HIV-related mortality in sub-Saharan Africa, however, screening for cryptococcal antigenemia has not be...

